Real-World Safety and Efficacy Clinical Data of an Improved Allergen-Specific Immunotherapy Product for the Treatment of Bee Venom Allergy

The aim of this study is to explore the safety and efficacy of bee venom immunotherapy without HSA, in real-life patients. Methods: This is an observational retrospective study developed in seven hospitals in Spain, where patients treated with this immunotherapy were included. They gathered the prot...

Descripción completa

Detalles Bibliográficos
Autores principales: Gonzalez Guzman, Luis Alfredo, García Robaina, Jose Carlos, Barrios Recio, Javier, Escudero Arias, Elena, Liñares Mata, Tania, Cervera Aznar, Raquel, De La Roca Pinzón, Federico, Miguel Polo, Lissette del Carmen, Arenas Villarroel, Luis, López Couso, Verónica P., Alcover Diaz, Javier, Rodriguez Gil, David, Pelaez, Ricardo Palacios, Carballada Gonzalez, Francisco Javier
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2023
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10222808/
https://www.ncbi.nlm.nih.gov/pubmed/37243083
http://dx.doi.org/10.3390/vaccines11050979

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10222808/
https://www.ncbi.nlm.nih.gov/pubmed/37243083
http://dx.doi.org/10.3390/vaccines11050979

Ejemplares similares